| 12/04/22 | 07:00:03 | 12 Apr 2022 | | Key Milestone Achieved on Galapagos Collaboration |
| 05/04/22 | 07:00:03 | 5 Apr 2022 | | Immuno-Oncology Research Collaboration with iTeos |
| 16/02/22 | 16:41:46 | 16 Feb 2022 | | Holding(s) in Company |
| 16/02/22 | 11:47:22 | 16 Feb 2022 | | Holding(s) in Company |
| 15/02/22 | 15:27:21 | 15 Feb 2022 | | Holding(s) in Company |
| 31/01/22 | 07:00:06 | 31 Jan 2022 | | Total Voting Rights |
| 20/01/22 | 10:58:49 | 20 Jan 2022 | | New Corporate Website |
| 18/01/22 | 16:41:49 | 18 Jan 2022 | | Holding(s) in Company |
| 07/01/22 | 07:00:05 | 7 Jan 2022 | | Director Dealing and Issue of Equity |
| 22/11/21 | 07:00:07 | 22 Nov 2021 | | Senior Management Update |
| 26/10/21 | 13:55:26 | 26 Oct 2021 | | Director Dealing |
| 26/10/21 | 07:01:02 | 26 Oct 2021 | | Interim results for six months ended 31 July 2021 |
| 26/10/21 | 07:00:04 | 26 Oct 2021 | | RNAi Platform Characterisation Results |
| 20/10/21 | 07:00:08 | 20 Oct 2021 | | Investor Presentation |
| 11/10/21 | 07:05:05 | 11 Oct 2021 | | Patent Filing Applications |
| 11/10/21 | 07:00:10 | 11 Oct 2021 | | Notice of Interim Results |
| 24/09/21 | 07:00:04 | 24 Sept 2021 | | Commencement of trading on the OTCQX Best Market |
| 02/09/21 | 16:41:20 | 2 Sept 2021 | | Second Price Monitoring Extn |
| 02/09/21 | 16:35:51 | 2 Sept 2021 | | Price Monitoring Extension |
